Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples (Q47872729)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2004

Language	Label	Description	Also known as
English	Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples	scientific article published in April 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

0 references

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Esther Oliva

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

author name string

Richard T Penson

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Steven J Skates

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Tina Glyptis

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Arlan F Fuller

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Annekathryn Goodman

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Michael V Seiden

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

93

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

98-106

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

BAX protein expression and clinical outcome in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

P-glycoprotein--a mediator of multidrug resistance in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Molecular mechanisms of multidrug resistance in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Interactions between antitumour agents and radiation and the expression of resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Detection of P-glycoprotein in frozen and paraffin-embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Biomarker conservation in primary and metastatic epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.053

7 January 2021

Identifiers

10.1016/J.YGYNO.2003.11.053

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15047220

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47872729&oldid=2173636972"